Literature DB >> 25265975

What is 'valvular' atrial fibrillation? A reappraisal.

Raffaele De Caterina1, A John Camm2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25265975     DOI： 10.1093/eurheartj/ehu352

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  37 in total

1.  Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons.

Authors:  J L Y Chee; X L Guan; J Y Lee; B Dong; S M Leong; E H Ong; A K F Liou; T M Lim
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

2.  Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.

Authors:  Joanna L d'Arcy; Sean Coffey; Margaret A Loudon; Andrew Kennedy; Jonathan Pearson-Stuttard; Jacqueline Birks; Eleni Frangou; Andrew J Farmer; David Mant; Jo Wilson; Saul G Myerson; Bernard D Prendergast
Journal:  Eur Heart J       Date:  2016-06-26       Impact factor: 29.983

3.  Safety and Feasibility of Treatment with Rivaroxaban for Non-Canonical Indications: A Case Series Analysis.

Authors:  Domenico Acanfora; Chiara Acanfora; Pietro Scicchitano; Marialaura Longobardi; Giuseppe Furgi; Gerardo Casucci; Bernardo Lanzillo; Ilaria Dentamaro; Annapaola Zito; Raffaele Antonelli Incalzi; Marco Matteo Ciccone
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

Review 4.  Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Authors:  Daniel Hammersley; Mark Signy
Journal:  Ther Adv Chronic Dis       Date:  2017-07-26       Impact factor: 5.091

Review 5.  Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?

Authors:  Sarah L Anderson; Joel C Marrs
Journal:  Curr Cardiol Rep       Date:  2019-08-31       Impact factor: 2.931

Review 6.  Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.

Authors:  Ryan E Owens; Rajesh Kabra; Carrie S Oliphant
Journal:  Clin Cardiol       Date:  2016-12-22       Impact factor: 2.882

7.  Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study.

Authors:  Mauro Molteni; Matteo Crippa; Annalisa Orenti; Hernan Polo Friz; Anna Menghini; Pierluigi Tramacere; Giuseppe Marano; Claudio Cimminiello; Patrizia Boracchi
Journal:  Clin Drug Investig       Date:  2019-04       Impact factor: 2.859

8.  Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke.

Authors:  Yunis Mayasi; Johanna Helenius; David D McManus; Richard P Goddeau; Adalia H Jun-O'Connell; Majaz Moonis; Nils Henninger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-27       Impact factor: 10.154

Review 9.  [Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].

Authors:  Thomas Maria Helms; Sigmund Silber; Andreas Schäfer; Florian Masuhr; Frederick Palm; Harald Darius; Karsten Schrör; Dietmar Bänsch; Peter Bramlage; Johannes Hankowitz; Christoph A Karle; Tom Stargardt; Joachim Weil; Johann Christoph Geller
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09

Review 10.  [Current state of treatment strategies for atrial fibrillation].

Authors:  C Rogge; S Hilbert; N Dagres; G Hindricks
Journal:  Herz       Date:  2016-05       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.